Combination drug therapy can significantly benefit patients with newly diagnosed blood cancer 02 Aug 2021 A four-drug combination therapy that includes the novel drug carfilzomib can slow the progression of the blood cancer myeloma in patients who have been newly diagnosed with the disease, a phase III study has shown. Find out more Show/Hide
Gene mutations linked with death from infection in patients with chronic lymphocytic leukaemia 07 Apr 2021 Death from infection – the leading cause of death for patients with a common type of leukaemia – is linked to specific gene mutations, a new study has found. Find out more Show/Hide
Resistance-busting ICR drug enters clinical trial 19 Mar 2021 A drug discovered at The Institute of Cancer Research that could counteract drug resistance in patients with cancers including acute myeloid leukaemia has entered a phase I clinical trial at The Royal Marsden NHS Foundation Trust. Find out more Show/Hide
First-degree relatives of blood cancer patients at increased risk, major new study reveals 20 Aug 2019
Pioneering scientist Mel Greaves is knighted after research to unveil cause of childhood leukaemia 28 Dec 2018
Professor Mel Greaves awarded prestigious Society of Memorial Sloan Kettering Prize for contributions to childhood cancer 25 Jun 2018